These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. Dalakas MC J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495 [TBL] [Abstract][Full Text] [Related]
6. [Not Available]. Wiendl H Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S20. PubMed ID: 26536184 [No Abstract] [Full Text] [Related]
10. Polymyositis: not a unicorn or mythological beast...but maybe a duck? Kissel JT Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286 [No Abstract] [Full Text] [Related]
11. Therapy for dermatomyositis and polymyositis. Rowland LP; Clark C; Olarte M Adv Neurol; 1977; 17():63-97. PubMed ID: 888742 [No Abstract] [Full Text] [Related]
12. [Exercise is beneficial for patients with myositis. Both pharmaceuticals and physical activity should be included in the therapy of chronic rheumatic muscle inflammation]. Lundberg IE; Alexanderson H; Arnardottir S; Borg K Lakartidningen; 2003 Sep; 100(36):2754-9. PubMed ID: 14558188 [No Abstract] [Full Text] [Related]
13. 64th ENMC International Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis29-31 January 1999, Naarden, The Netherlands. Müller-Felber W; Pongratz D; Reimers C Neuromuscul Disord; 2001 Jan; 11(1):88-92. PubMed ID: 11166170 [No Abstract] [Full Text] [Related]
14. [Essential points to remember]. Letonturier P Presse Med; 2003 Oct; 32(35):1676. PubMed ID: 14631272 [No Abstract] [Full Text] [Related]
15. Polymyositis/dermatomyositis: the current position. Urbano-Márquez A; Casademont J; Grau JM Ann Rheum Dis; 1991 Mar; 50(3):191-5. PubMed ID: 2015017 [No Abstract] [Full Text] [Related]
16. Inflammatory myopathies: evaluation and management. Greenberg SA Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525 [TBL] [Abstract][Full Text] [Related]